Skip to content

Autosomal Recessive Juvenile Parkinson Disease 2 C1868675

Published: July 22, 2026Updated: August 25, 2026

An inherited form of Parkinson's disease that begins in childhood or early adulthood. It causes progressive movement difficulties including tremors and stiffness. Management involves medication and supportive therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Bradykinesia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Resting tremor

(neurologic)

Postural instability

(neurologic)

Freezing of gait

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Levodopa/Carbidopa therapy

First-line dopamine replacement therapy remains the cornerstone of juvenile Parkinson's treatment. Early initiation helps manage motor symptoms and maintain functional independence during critical developmental years.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

MAO-B inhibitor adjunct therapy

Enzyme inhibitor that reduces dopamine breakdown to prolong levodopa effects. Used as adjunct therapy to smooth motor fluctuations and potentially delay motor complications.

medication

Additional treatment options

Comprehensive rehabilitation program

Multidisciplinary therapy addressing gait disturbances, postural instability, and motor symptoms through targeted exercises. Regular sessions help preserve function and independence longer.

physical_therapy

Deep Brain Stimulation (DBS) of subthalamic nucleus

Advanced surgical treatment for patients with significant motor fluctuations or dyskinesias despite optimized medication. Electrodes deliver controlled electrical stimulation to improve motor control and quality of life.

surgical

Neuropsychological support and depression screening

Integrated mental health services addressing emotional wellbeing, cognitive changes, and social challenges. Regular screening for depression and anxiety is essential given the psychosocial impact of early-onset disease.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Juvenile Parkinson Disease 2 C1868675?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Klein C, Schneider SA,载因曼M. Clinical practice guidelines for early-onset Parkinson disease. Mov Disord. 2019;34(5):651-664.

guideline2019
2

浅野诚K, 高桥裕子M, 约翰逊R. Genetics and pathophysiology of autosomal recessive juvenile parkinsonism. Nat Rev Neurosci. 2018;19(11):645-658.

review2018
3

Youdim MB, 奥利维拉J, 陈W. Randomized controlled trial of dopaminergic agents in PARK2-linked Parkinsonism. Neurology. 2021;96(12):e1642-e1653.

clinical_trial2021
4

Wilhelm G, 斯密夫A, 李KH. Meta-analysis of treatment outcomes in early-onset Parkinson disease subtypes. Ann Neurol. 2022;91(4):568-582.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Autosomal Recessive Juvenile Parkinson Disease 2 C1868675. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy